Cell cycle–related kinase links androgen receptor and β‐catenin signaling in hepatocellular carcinoma: Why are men at a loss?
Prince K. Awuah, Satdarshan P. Monga – 23 February 2012
Can propranolol be a viable option for the treatment of small‐for‐size syndrome?
Young‐Dong Yu, Dong‐Sik Kim, Geon‐Young Byun, Sung‐Ock Seo – 23 February 2012
Is liver transplantation feasible in patients coinfected with human immunodeficiency virus and hepatitis C virus?
Umberto Baccarani, Luigia Scudeller, Gian Luigi Adani, Pierluigi Viale, Marcello Tavio – 23 February 2012
Treatment of an elderly patient with hepatocellular carcinoma: Counseling from the patient's point of view
James D. Perkins – 23 February 2012
Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes
Chapy Venkatesan, Zobair M. Younossi – 23 February 2012
Mice with artificial human liver
Akihide Kamiya, Atsushi Miyajima – 23 February 2012
Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C–related cirrhosis with occult hepatocellular carcinoma: A case report
Andrew C. Nelson, Jose Jessurun, Randolph K. Peterson, Stefan E. Pambuccian – 17 February 2012
Relationship between sleep problems and health‐related quality of life among pediatric liver transplant recipients
Emily M. Fredericks, Dawn Dore‐Stites, Sheyla Y. Calderon, Andrew Well, Sally J. Eder, John C. Magee, M. James Lopez – 17 February 2012 – Among adult liver transplant recipients (LTRs), sleep disturbances and fatigue are common. Sleep problems following pediatric liver transplantation may contribute to daytime fatigue and lower health‐related quality of life (HRQOL). The aim of this cross‐sectional study was to determine the impact of sleep problems on the HRQOL of pediatric LTRs using validated measures. Participants included 47 LTRs.
Pregnancy outcomes of liver transplant recipients: A systematic review and meta‐analysis
Neha A. Deshpande, Nathan T. James, Lauren M. Kucirka, Brian J. Boyarsky, Jacqueline M. Garonzik‐Wang, Andrew M. Cameron, Andrew L. Singer, Nabil N. Dagher, Dorry L. Segev – 17 February 2012 – Approximately 14,000 women of reproductive age are currently living in the United States after liver transplantation (LT), and another 500 undergo LT each year. Although LT improves reproductive function in women with advanced liver disease, the associated pregnancy outcomes and maternal‐fetal risks have not been quantified in a broad manner.
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological‐pathological correlation
Sharon W. Kwan, Nicholas Fidelman, Elizabeth Ma, Robert K. Kerlan, Francis Y. Yao – 17 February 2012 – Transarterial chemoembolization (TACE) is one of the standard therapies for bridging patients with hepatocellular carcinoma (HCC) to transplantation. This study was designed to determine which features on pre‐ and post‐TACE imaging are associated with tumor necrosis in pathological specimens. Records of 105 patients with 132 HCC lesions who underwent liver transplantation after TACE were retrospectively reviewed. In 70% of the nodules, >90% necrosis was achieved.